Value assessment of deprescribing interventions: Suggestions for improvement.

Anna Hung, Jinjiao Wang, Frank Moriarty, Veena Manja, Tesfahun Eshetie, Henok Getachew Tegegn, Timothy S Anderson, Thomas R Radomski, Michael A Steinman
Author Information
  1. Anna Hung: Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.
  2. Jinjiao Wang: Elaine Hubbard Center for Nursing Research on Aging, School of Nursing, University of Rochester, Rochester, New York, USA. ORCID
  3. Frank Moriarty: School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland. ORCID
  4. Veena Manja: Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, California, USA.
  5. Tesfahun Eshetie: Registry of Senior Australians. Healthy Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, Australia.
  6. Henok Getachew Tegegn: School of Rural Medicine, University of New England, Armidale, Australia.
  7. Timothy S Anderson: Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. ORCID
  8. Thomas R Radomski: Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. ORCID
  9. Michael A Steinman: Division of Geriatrics, University of California San Francisco, San Francisco, California, USA. ORCID

Abstract

No abstract text available.

References

  1. J Am Geriatr Soc. 2022 Jun;70(6):1764-1773 [PMID: 35266141]
  2. PLoS One. 2021 Aug 3;16(8):e0255642 [PMID: 34343225]
  3. Circ Heart Fail. 2021 Nov;14(11):e008293 [PMID: 34674539]
  4. J Am Geriatr Soc. 2022 Sep;70(9):2487-2497 [PMID: 35648465]
  5. BMJ Open. 2018 Jan 11;8(1):e018880 [PMID: 29330175]
  6. Pilot Feasibility Stud. 2022 Sep 10;8(1):203 [PMID: 36088445]
  7. JAMA Intern Med. 2015 May;175(5):827-34 [PMID: 25798731]
  8. Value Health. 2014 Jan-Feb;17(1):5-14 [PMID: 24438712]
  9. J Palliat Med. 2018 Mar;21(S2):S17-S27 [PMID: 29091522]
  10. JAMA Intern Med. 2018 Dec 1;178(12):1673-1680 [PMID: 30326004]
  11. Value Health. 2018 Feb;21(2):131-139 [PMID: 29477390]
  12. Pharmacoeconomics. 2022 Mar;40(3):269-295 [PMID: 34913143]
  13. BMJ Open. 2019 Jan 30;9(1):e021832 [PMID: 30705233]
  14. Hypertension. 2022 May;79(5):1122-1131 [PMID: 35266409]
  15. BMC Geriatr. 2021 Apr 17;21(1):258 [PMID: 33865310]

Grants

  1. R03 AG064373/NIA NIH HHS
  2. R24 AG064025/NIA NIH HHS
  3. P01 AG066605/NIA NIH HHS
  4. K24 AG049057/NIA NIH HHS
  5. IK2 HX003359/HSRD VA
  6. P30 AG044281/NIA NIH HHS
  7. K76 AG074878/NIA NIH HHS
  8. K23 AG061217/NIA NIH HHS

MeSH Term

Humans
Deprescriptions
Inappropriate Prescribing
Polypharmacy